The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Tau oligomers and aggregation in Alzheimer’s disease
Abstract
J. Neurochem.(2010)112, 1353–1367. We are analyzing the physiological function of Tau protein and its abnormal pathological behavior when this protein is self‐assemble into pathological filaments. These aggregates of Tau protein are the main components in many diseases such as Alzheimer’s disease (AD). Recent studies suggest that Tau acquires complex oligomeric conformations which may be toxic. In this review, we emphasized the possible phenomena implicated in the formation of these oligomers. Studies with chemical inductors indicates that the microtubule‐binding domain is the most important region involved in Tau aggregation and showed the requirement of a pre‐arrange Tau in abnormal conformation to promote self‐assembly. Transgenic animal models and AD neuropathology studies showed that post‐translational modifications are also implicated in Tau aggregation and neural cell death during AD development. Therefore, we analyzed some events that could be present during Tau aggregation. Finally, we included a brief discussion of the possible relation between glucose metabolism dysfunction in AD, and data of Tau aggregation by using aggregation inhibitors. In conclusion, the process Tau aggregation deserves further investigations to design possible therapeutic targets to inhibit the toxicity of these aggregates and it is possible that could be extended to other diseases with similar etiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 2×
“The association of Ubiquitin with PHF is such that is the only protein which remains bound to PHF after their treatment with Pronase (Goedert et al. 1988).”
BackgroundGoedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036 · cited 4×
“306– 311 or 317–335 amino acids corresponding to a segment of the third repeat (Goedert et al. 1996; von Bergen et al. 2000; Pérez et al. 2001).”
BackgroundInfluentialTau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
Williams, D. R., & Lees, A. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70042-0 · Cited by 650
Tau phosphorylation in neuronal cell function and dysfunction
Johnson, G. V. W., & Stoothoff, W. H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01558 · Cited by 624
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585
Research works printed but not linked: 112
- Abraha A., 2000, C‐terminal inhibition of tau assembly in vitro and in Alzheimer’s disease, J. Cell Sci., 113, 3737, 10.1242/jcs.113.21.3737 · DOI · Paper page
- 10.1136/jnnp.52.5.600 · DOI
- 10.1073/pnas.94.1.298 · DOI · Paper page
- 10.1073/pnas.121119298 · DOI · Paper page
- Arai T., 2005, Proteolysis of non‐phosphorylated and phosphorylated Tau by Thrombin, J. Cell Biol., 280, 5145
- 10.1152/physrev.00024.2003 · DOI · Paper page
- 10.1074/jbc.M700192200 · DOI
- 10.1097/NEN.0b013e31817275c7 · DOI
- 10.1073/pnas.97.10.5129 · DOI · Paper page
- 10.1523/JNEUROSCI.0587-07.2007 · DOI · Paper page
- 10.1016/j.bbadis.2004.08.014 · DOI · Paper page
- 10.1016/j.bbadis.2004.06.018 · DOI · Paper page
- 10.1016/S0165-0173(00)00019-9 · DOI · Paper page
- 10.1002/anie.200704051 · DOI
- 10.1021/bi700403a · DOI
- 10.1021/bi0500123 · DOI · Paper page
- 10.1016/j.abb.2007.05.004 · DOI
- 10.1074/jbc.M800247200 · DOI
- 10.1074/jbc.M109.016089 · DOI
- 10.1074/jbc.M512786200 · DOI · Paper page
- 10.1007/BF01991785 · DOI
- 10.1111/j.1365-2990.1995.tb01065.x · DOI
- 10.1096/fj.07-096909 · DOI
- 10.1523/JNEUROSCI.0746-06.2006 · DOI · Paper page
- 10.3233/JAD-2008-14413 · DOI
- 10.1002/cm.20243 · DOI
- 10.1083/jcb.143.3.777 · DOI · Paper page
- 10.1016/j.pbb.2008.08.003 · DOI
- 10.1046/j.1471-4159.2000.0750624.x · DOI · Paper page
- 10.1021/bi0272510 · DOI
- 10.1016/S0891-0618(01)00096-5 · DOI
- 10.1111/j.1365-2990.1987.tb00174.x · DOI · Paper page
- 10.1007/s00401-007-0209-6 · DOI
- 10.1007/s00018-007-7220-x · DOI · Paper page
- 10.1016/j.neulet.2003.12.049 · DOI
- 10.1248/cpb.55.1030 · DOI
- Holzter M., 2002, Inverse association of Pin1 and tau accumulation in Alzheimer’s disease hippocampus, Acta Neuropathol., 104, 471, 10.1007/s00401-002-0581-1 · DOI
- 10.1021/bi061325g · DOI
- 10.1016/j.brainres.2006.10.085 · DOI
- 10.1016/S1570-9639(02)00538-1 · DOI
- 10.1111/j.1582-4934.2008.00225.x · DOI · Paper page
- 10.1017/S1041610208008132 · DOI
- 10.1016/j.bbrc.2006.04.032 · DOI
- 10.1016/S0014-5793(96)01386-5 · DOI · Paper page
- 10.1016/j.coi.2009.05.001 · DOI
- 10.1074/jbc.M507753200 · DOI · Paper page
- 10.1021/bi9911839 · DOI
- 10.1021/bi048549o · DOI
- 10.1111/j.1460-9568.2008.06329.x · DOI
- 10.1002/jemt.20188 · DOI
- 10.1001/archneur.65.5.650 · DOI
- 10.1002/jemt.20187 · DOI
- 10.3233/JAD-2009-1116 · DOI
- 10.1242/jcs.111.21.3167 · DOI · Paper page
- 10.1371/journal.pcbi.1000238 · DOI
- 10.1152/physiolgenomics.00208.2006 · DOI · Paper page
- 10.1111/j.1471-4159.2007.04792.x · DOI
- 10.1007/978-0-387-87995-6_8 · DOI
- 10.1016/S0014-5793(02)03487-7 · DOI · Paper page
- Liu Y.‐H., 2008, Protesosome inhibition increases tau accumulation independent of phosphorylation, Neurobiol. Aging, 30, 1949, 10.1016/j.neurobiolaging.2008.02.012 · DOI
- 10.1021/bi800732v · DOI
- 10.1093/brain/awp099 · DOI · Paper page
- 10.1136/jnnp.72.2.152 · DOI
- 10.1111/j.1468-1331.2008.02513.x · DOI · Paper page
- 10.3233/JAD-2007-12410 · DOI · Paper page
- 10.1021/bi061359o · DOI · Paper page
- 10.1074/jbc.M305207200 · DOI
- 10.1073/pnas.85.12.4501 · DOI · Paper page
- 10.1523/JNEUROSCI.2824-07.2008 · DOI · Paper page
- 10.1111/j.1365-2613.2007.00568.x · DOI
- 10.1016/0014-5793(88)80304-1 · DOI
- 10.1007/BF03161077 · DOI
- 10.1186/1471-2202-8-9 · DOI
- 10.1371/journal.pone.0000629 · DOI
- 10.1017/S146239940800080X · DOI
- 10.1021/bi002961w · DOI
- 10.1021/bi702466a · DOI
- 10.1074/jbc.M410984200 · DOI · Paper page
- 10.1021/bi700878g · DOI
- 10.1016/j.nbd.2008.04.005 · DOI
- 10.1021/bi051028w · DOI
- 10.1523/JNEUROSCI.2143-06.2006 · DOI
- 10.1021/bi700430y · DOI
- 10.4103/0028-3886.30420 · DOI
- 10.1155/JBB/2006/73976 · DOI
- 10.1073/pnas.0802036105 · DOI · Paper page
- 10.1111/j.1471-4159.2008.05716.x · DOI
- 10.1111/j.1460-9568.2007.05555.x · DOI · Paper page
- 10.1002/jnr.21417 · DOI
- Sánchez M. P., 2001, La proteína tau en enfermedades neurodegenerativas Taupatías, Rev. Neurol., 33, 169, 10.33588/rn.3302.2001187 · doi:10.33588/rn.3302.2001187
- 10.1126/science.1113694 · DOI · Paper page
- 10.1007/s11010-005-7499-6 · DOI
- 10.1016/j.neulet.2007.09.068 · DOI
- 10.1016/S0014-5793(01)02421-8 · DOI
- 10.1111/j.1471-4159.2006.04059.x · DOI
- 10.1021/bi061830d · DOI
- 10.1016/j.febslet.2004.04.098 · DOI
- Skrabana R., 2006, Intrinsically disordered proteins in the neurodegenerative process: formation of Tau protein paired helical filaments and their analysis, Cell.Mol. Neurobiol., 26, 1085
- 10.1016/j.bbrc.2009.05.047 · DOI
- 10.1007/s00018-007-7270-0 · DOI · Paper page
- 10.1074/jbc.M408714200 · DOI · Paper page
- 10.1016/j.pneurobio.2008.03.002 · DOI · Paper page
- 10.1073/pnas.0703676104 · DOI · Paper page
- 10.1073/pnas.72.5.1858 · DOI · Paper page
- 10.1007/s00401-006-0053-0 · DOI
- 10.1073/pnas.85.12.4506 · DOI · Paper page
- 10.1073/pnas.85.13.4884 · DOI · Paper page
- 10.1073/pnas.93.20.11213 · DOI · Paper page
- 10.1111/j.1432-1033.1995.009_1.x · DOI · Paper page
- 10.1016/j.bbrc.2008.07.101 · DOI
- 10.1016/j.febslet.2005.03.041 · DOI
- 10.1016/j.febslet.2006.05.029 · DOI · Paper page
Cited by
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 641
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Sarmiento, J., Troncoso, J., Jackson, G. R., & Kayed, R. (2012) · The FASEB Journal · doi:10.1096/fj.11-199851 · Cited by 527
Metadata
- Authors
- Meraz‐Ríos, M. A., Lira‐De León, K. I., Campos‐Peña, V., De Anda‐Hernández, M. A., & Mena‐López, R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2010-02-22
- Volume
- 112
- Issue
- 6
- Pages
- 1353-1367
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1994085255
- Cited by
- 191
- References
- 28
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tau oligomers and aggregation in Alzheimer’s disease. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.06511.x
- The paper
- Meraz‐Ríos, M. A., Lira‐De León, K. I., Campos‐Peña, V., De Anda‐Hernández, M. A., & Mena‐López, R. (2010). Tau oligomers and aggregation in Alzheimer’s disease. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.06511.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.